X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9635) 9635
Book Review (808) 808
Newsletter (458) 458
Publication (297) 297
Book Chapter (50) 50
Conference Proceeding (34) 34
Magazine Article (29) 29
Web Resource (20) 20
Dissertation (16) 16
Book / eBook (8) 8
Newspaper Article (5) 5
Paper (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (6915) 6915
index medicus (6884) 6884
hyperbilirubinemia (4756) 4756
male (3542) 3542
female (3528) 3528
infant, newborn (3502) 3502
pediatrics (2028) 2028
bilirubin - blood (2027) 2027
bilirubin (1849) 1849
adult (1565) 1565
jaundice (1537) 1537
animals (1242) 1242
abridged index medicus (1238) 1238
phototherapy (1160) 1160
infants (1141) 1141
infant (956) 956
middle aged (956) 956
hyperbilirubinemia - etiology (942) 942
pregnancy (839) 839
rats (805) 805
risk factors (784) 784
research (703) 703
adolescent (696) 696
bilirubin - metabolism (665) 665
neonatal jaundice (664) 664
kernicterus (635) 635
neonatal hyperbilirubinemia (626) 626
hyperbilirubinemia - therapy (605) 605
old medline (583) 583
hyperbilirubinemia - blood (575) 575
child (549) 549
aged (534) 534
hyperbilirubinemia - complications (518) 518
liver (499) 499
newborn (482) 482
hyperbilirubinemia - diagnosis (472) 472
retrospective studies (460) 460
liver - metabolism (445) 445
care and treatment (438) 438
management (425) 425
health aspects (401) 401
time factors (399) 399
glucuronosyltransferase - genetics (394) 394
infant, premature (394) 394
gastroenterology & hepatology (391) 391
gestational age (389) 389
diagnosis (388) 388
exchange transfusion, whole blood (386) 386
child, preschool (383) 383
jaundice, neonatal - therapy (383) 383
obstetrics & gynecology (380) 380
hyperbilirubinemia - chemically induced (373) 373
diagnosis, differential (371) 371
prospective studies (356) 356
pharmacology & pharmacy (353) 353
analysis (345) 345
treatment outcome (341) 341
medicine, general & internal (339) 339
hyperbilirubinemia - metabolism (337) 337
liver - pathology (318) 318
liver function tests (316) 316
surgery (303) 303
hemolysis (296) 296
birth weight (292) 292
hyperbilirubinemia, neonatal - therapy (292) 292
serum bilirubin (290) 290
neonates (284) 284
hematology (275) 275
jaundice, neonatal - blood (274) 274
jaundice, neonatal - diagnosis (264) 264
follow-up studies (260) 260
children (259) 259
mutation (259) 259
risk (255) 255
newborns (251) 251
blood (244) 244
gilberts-syndrome (237) 237
hyperbilirubinemia, neonatal - diagnosis (236) 236
babies (235) 235
oncology (235) 235
medicine & public health (231) 231
cholestasis (227) 227
reports (227) 227
prognosis (223) 223
neonate (220) 220
hyperbilirubinemia - drug therapy (219) 219
disease (218) 218
liver diseases (211) 211
incidence (209) 209
breast feeding (207) 207
liver - enzymology (207) 207
hyperbilirubinemia - genetics (206) 206
medical research (204) 204
hyperbilirubinemia - epidemiology (203) 203
hyperbilirubinemia, hereditary (203) 203
hyperbilirubinemia, neonatal - blood (202) 202
jaundice, neonatal - etiology (201) 201
hyperbilirubinemia, hereditary - diagnosis (200) 200
transplantation (200) 200
biochemistry & molecular biology (196) 196
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8136) 8136
German (499) 499
Italian (269) 269
French (262) 262
Japanese (187) 187
Spanish (182) 182
Russian (153) 153
Polish (84) 84
Chinese (63) 63
Portuguese (63) 63
Czech (61) 61
Hungarian (43) 43
Korean (36) 36
Dutch (26) 26
Turkish (25) 25
Romanian (20) 20
Persian (18) 18
Danish (14) 14
Serbian (14) 14
Swedish (12) 12
Bulgarian (11) 11
Croatian (11) 11
Slovak (8) 8
Norwegian (7) 7
Hebrew (6) 6
Ukrainian (6) 6
Slovenian (4) 4
Arabic (3) 3
Finnish (2) 2
Afrikaans (1) 1
Azerbaijani (1) 1
Icelandic (1) 1
Lithuanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
01/2014
Objective: Jaundice is a common problem in neonatal period. Phototherapy is the most common treatment for neonatal jaundice. The purpose of this study was to... 
Jaundice | Neonate | Hyperbilirubinemia | Phototherapy
Web Resource
Journal of clinical investigation, ISSN 0021-9738, 2012, Volume 122, Issue 2, pp. 519 - 528
Journal Article
The Journal of Pediatrics, ISSN 0022-3476, 09/2019, Volume 212, pp. 243 - 244
Journal Article
Archives of Disease in Childhood - Fetal and Neonatal Edition, ISSN 1359-2998, 09/2007, Volume 92, Issue 5, pp. F342 - F346
Journal Article
Journal Article
BMC pediatrics, ISSN 1471-2431, 2017, Volume 17, Issue 1, pp. 32 - 32
Journal Article
Journal Article
Biochemical Pharmacology, ISSN 0006-2952, 06/2016, Volume 110-111, pp. 37 - 46
Humanized UDP-glucuronosyltransferase ( )- ( ) mice encode the locus including the gene. During neonatal development, delayed expression of the gene leads to... 
Oxidative stress | Humanized UGT1 mice | Inflammation | Bilirubin | Intestinal IKKβ | UDP-glucuronosyltransferase 1A1 | ACTIVATION | GLUCURONIDATION | PREVENTION | IKK | BETA | UDP-GLUCURONOSYLTRANSFERASE-1 | BILIRUBIN TOXICITY | Intestinal IKK beta | NEONATAL HYPERBILIRUBINEMIA | PHARMACOLOGY & PHARMACY | INHIBITOR | Intestines - drug effects | Tumor Necrosis Factor-alpha - metabolism | Epithelial Cells - metabolism | Seizures - genetics | Seizures - prevention & control | Hyperbilirubinemia - prevention & control | Epithelial Cells - drug effects | Humans | Tumor Necrosis Factor-alpha - genetics | NF-kappa B - metabolism | Seizures - metabolism | Gene Expression Profiling | Intestines - metabolism | Hyperbilirubinemia - metabolism | Interleukin-1beta - genetics | Weight Loss - drug effects | Bilirubin - biosynthesis | Glucuronosyltransferase - genetics | Seizures - pathology | Interleukin-1beta - metabolism | Interleukin-6 - metabolism | Animals, Newborn | Hyperbilirubinemia - genetics | I-kappa B Kinase - deficiency | Intestines - pathology | Bilirubin - antagonists & inhibitors | Interleukin-6 - genetics | Signal Transduction | Gene Expression Regulation | Cadmium - pharmacology | Epithelial Cells - pathology | Mice, Transgenic | I-kappa B Kinase - genetics | Animals | Glucuronosyltransferase - metabolism | NF-kappa B - genetics | Arsenic - pharmacology | Hyperbilirubinemia - pathology | Mice | Oxidative Stress - drug effects | Index Medicus
Journal Article
Current Pediatric Reviews, ISSN 1573-3963, 08/2017, Volume 13, Issue 3, p. 158
Journal Article
07/2008
Objective: Clofibrate has been used for several years as a hypolipidemic drug. Our aim was to study the effect of Clofibrate on neonatal hyperbilirubinemia in... 
Jaundice | Neonate | Hyperbilirubinemia | Clofibrate
Web Resource
Journal of Maternal-Fetal and Neonatal Medicine, ISSN 1476-7058, 2018, pp. 1 - 6
Preterm infants are prone to increased bilirubin burden and display adverse outcomes if left unmonitored; therefore, predicting an increased bilirubin... 
Carboxyhemoglobin | hyperbilirubinemia | newborn
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2015, Volume 10, Issue 4, pp. e0123670 - e0123670
Introduction Ritonavir-boosted atazanavir (ATV/r) is a relatively well tolerated antiretroviral drug. However, side effects including hyperbilirubinemia,... 
UNBOOSTED ATAZANAVIR | BILIRUBIN | HYPERBILIRUBINEMIA | EFFICACY | PHARMACOKINETICS | TOLERABILITY | MULTIDISCIPLINARY SCIENCES | ANTIRETROVIRAL THERAPY | RENAL STONES | POLYMORPHISM | RITONAVIR-BOOSTED ATAZANAVIR | Nephrolithiasis - chemically induced | Atazanavir Sulfate - administration & dosage | Humans | Middle Aged | Male | Atazanavir Sulfate - adverse effects | Atazanavir Sulfate - pharmacokinetics | Drug Dosage Calculations | Dyslipidemias - blood | HIV-1 - physiology | Ritonavir - adverse effects | HIV Protease Inhibitors - pharmacokinetics | Hyperbilirubinemia - chemically induced | Adult | Female | Hyperbilirubinemia - physiopathology | Nephrolithiasis - physiopathology | Dyslipidemias - diagnosis | HIV Protease Inhibitors - adverse effects | HIV Protease Inhibitors - blood | Atazanavir Sulfate - blood | Drug Administration Schedule | Hyperbilirubinemia - diagnosis | HIV-1 - drug effects | HIV Infections - virology | Nephrolithiasis - blood | HIV Protease Inhibitors - administration & dosage | Nephrolithiasis - diagnosis | Antiretroviral Therapy, Highly Active | Hyperbilirubinemia - blood | Dyslipidemias - chemically induced | HIV Infections - drug therapy | Drug Monitoring | Viral Load - drug effects | Dyslipidemias - physiopathology | Highly active antiretroviral therapy | HIV patients | HIV (Viruses) | Health aspects | HIV infection | Analysis | Antiretroviral drugs | Toxicity | Ritonavir | Complications | Dyslipidemia | Lipids | Nephrolithiasis | Dosage | Patients | Side effects | Hyperbilirubinemia | Acquired immune deficiency syndrome--AIDS | Protease inhibitors | Antiretroviral agents | Human immunodeficiency virus--HIV | All terrain vehicles | Index Medicus | AIDS | HIV | Acquired immune deficiency syndrome | Human immunodeficiency virus
Journal Article
Journal Article